Medicare
The Centers for Medicare & Medicaid Services (CMS) on June 12 issued a final rule revising its oversight of accrediting organizations (AOs) that evaluate hospitals and other healthcare providers for compliance with Medicare’s Conditions of Participation (CoPs).
The Department of Health and Human Services and the Centers for Medicare & Medicaid Services released a proposed rule June 12 seeking to codify the Medicare Drug Price Negotiation Program in regulation.
The Centers for Medicare & Medicaid Services June 12 issued a final rule revising how the agency conducts oversight of accrediting organizations that ensure that hospitals and other healthcare providers are in compliance with the Medicare Conditions of Participation.
The Hospital Insurance Trust Fund has been projected to become insolvent in 2033, according to the Medicare Board of Trustees’ annual report released June 9.
The Centers for Medicare & Medicaid Services has released details on downloading its upcoming fiscal year 2025 Program for Evaluating Payment Patterns Electronic Report, or PEPPER, for critical access hospitals.
The Department of Health and Human Services Administration for Community Living has launched the first phase of its Health at Home Challenge, a competition to support community care networks that have partnered with health care providers supporting dually eligible Medicare and Medicaid…
The AHA shared a statement with the media in response to a report released May 7 by Families USA.
The Centers for Medicare & Medicaid Services announced May 6 that it will provide access to certain glucagon-like peptide-1 (GLP-1) medications to eligible Medicare Part D beneficiaries for $50 per month beginning July 1 this year through Dec. 31, 2027.
AHA comments on the Centers for Medicare & Medicaid Services’ revised Medicare Part C and D Reporting requirements.
This webinar explains how Medicare set payment rates for clinical laboratory tests and why upcoming reporting deadlines were so important. Speakers review recent policy developments, long-standing concerns about whether reported data accurately reflected the full laboratory market, and provides…